がん薬物療法
がん化学療法レジメン
大腸がん
- mFOLFOX6
- FOLFIRI
- SOX
- XELOX
- IRIS
- mXELIRI
- sLV5FU2
- pembrolizumab(MSI-highの症例に限る)
- Bmab+mFOLFOX6
- Bmab+FOLFIRI
- Bmab+SOX
- Bmab+XELOX
- Bmab+IRIS
- Bmab+mXELIRI
- Bmab+Capecitabine
- Bmab+TAS-102
- Bmab+TAS-102(biweekly)
- Bmab+UFT/LV
- Bmab+FOLFOXIRI
- Cmab+mFOLFOX6
- Cmab+FOLFIRI
- Cmab+CPT-11
- Cmab単剤
- Pmab+mFOLFOX6
- Pmab+FOLFIRI
- Pmab+IRIS
- Pmab+CPT-11
- Pmab単剤
- RAM+FOLFIRI
- aflibercept+FOLFIRI
- Cmab+Encorafenib+Binimetinib
- Bmab+FL
- SIRB
お問い合わせ先
0570-01-1114